Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.
about
Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Comparison of the effectivenes ...... and rare EGFR gene mutations.
@ast
Comparison of the effectivenes ...... and rare EGFR gene mutations.
@en
type
label
Comparison of the effectivenes ...... and rare EGFR gene mutations.
@ast
Comparison of the effectivenes ...... and rare EGFR gene mutations.
@en
prefLabel
Comparison of the effectivenes ...... and rare EGFR gene mutations.
@ast
Comparison of the effectivenes ...... and rare EGFR gene mutations.
@en
P2093
P2860
P50
P356
P1433
P1476
Comparison of the effectivenes ...... n and rare EGFR gene mutations
@en
P2093
Aleksander Barinow-Wojewódzki
Janusz Milanowski
Katarzyna Reszka
Maciej Bryl
P2860
P304
P356
10.3892/OL.2017.5980
P50
P577
2017-04-03T00:00:00Z